Business
From Lab to Global Impact: Polyrizon's Journey to Potentially Redefining Next-Generation Nasal Protection
Ra’anana, Israel , Dec. 04, 2025 (GLOBE NEWSWIRE) -- In an era where airborne threats like allergens and viruses disrupt daily life for millions, a small biotech innovator in Israel is quietly reshaping approaches to respiratory defense. Polyrizon Ltd. (Nasdaq: PLRZ), a development-stage biotechnology company, aims to transform a bold lab-born vision into a scalable reality. With the recent announcement of a pivotal manufacturing milestone, Polyrizon is no longer just a promising startup—it is a
About this update from Polyrizon Ltd.
[{"type":"text","content":"Ra’anana, Israel , Dec. 04, 2025 (GLOBE NEWSWIRE) -- In an era where airborne threats like allergens and viruses disrupt daily life for millions, a small biotech innovator in Israel is quietly reshaping approaches to respiratory defense. Polyrizon Ltd. (Nasdaq: PLRZ), a development-stage biotechnology company, aims to transform a bold lab-born vision into a scalable reality. With the recent announcement of a pivotal manufacturing milestone, Polyrizon is no longer just a promising startup—it is advancing its efforts to develop non-pharmacological solutions that could shield global populations from seasonal woes and beyond.","length":629,"tagName":"p"},{"type":"text","content":"Founded by visionary entrepreneur Tomer Izraeli, Polyrizon emerged from a simple yet profound insight: the nose, as the body's frontline gateway to the lungs, deserves smarter protection. Izraeli, a serial innovator with over 18 years of experience in medical devices and pharmaceuticals, spotted a gap in traditional nasal sprays—products that often provide temporary relief but fail to create lasting barriers against invaders. Drawing on his background in business development and R&D, he assembled a world-class team to pioneer the company's proprietary Capture & Contain™ (C&C) platform. This hydrogel-based technology deploys a thin, bio-adhesive shield via nasal spray, acting like a "biological mask" to trap, isolate, and neutralize airborne particles before they trigger inflammation.","length":824,"tagName":"p"},{"type":"text","content":"What began as small-batch experiments in Polyrizon’s labs has now progressed into meaningful scale-up achievements, paving the way toward full manufacturing capability as Polyrizon continues advancing toward industrial-scale production. The company's flagship product, PL-14 Allergy Blocker, exemplifies this evolution. This innovative intranasal spray forms a fast-acting, moisturizing barrier in the nasal cavity, designed to capture allergens, such as pollen, dust, and pet dander. Unlike antihistamine-laden alternatives that mask symptoms, PL-14 offers extended, drug-free protection—ideal for allergy sufferers navigating high-exposure environments, like urban commutes or outdoor seasons.","length":699,"tagName":"p"},{"type":"text","content":"The company believes that this non-pharmacological...